Bayer is selling its Environmental Science Professionals business to Cinven for $2.6 billion – Advice Eating

LEVERKUSEN, Germany–(BUSINESS WIRE)–Bayer and Cinven have reached a definitive agreement to sell Bayer’s Environmental Science Professionals business for a purchase price of $2.6 billion, Bayer announced Thursday. “This divestment represents a very attractive purchase price and allows us to focus on our core agricultural business and the successful execution of our growth strategy in the Crop Science division,” said Rodrigo Santos, Member of the Board of Management of Bayer AG and President of the Crop Science Division.

Environmental Science Professional is a leading global provider of environmental solutions for pest, disease and weed control in non-agricultural sectors such as vector control, professional pest control, vegetation management, forestry, and turf and ornamental crops. In 2021, the company had around 800 employees supporting operations and sales in more than 100 countries. It is headquartered in Cary, North Carolina, USA. Bayer announced its decision to sell the business in February 2021.

Driven by a shared belief in people and purpose, Cinven will enable Environmental Science Professional to move closer to its vision of a healthy environment for everyone, everywhere. We believe in Cinven’s focus and commitment to the long-term growth potential of the company and its people,” said Santos. The transaction is expected to close in the second half of this year, subject to the satisfaction of customary closing conditions. The net proceeds will be used to reduce Bayer’s net financial debt.

Bayer’s Environmental Science Professionals business is a global leader in a highly attractive and critical industry. We thank Bayer for the trust they have shown in Cinven and we plan to build on Bayer’s strong foundation by investing significantly in the company,” said Pontus Pettersson, Partner and Head of Industrial at Cinven. “As a long-established global investment firm, Cinven is well positioned to drive innovation and accelerate growth in the Environmental Science Professional, including the delivery of digital and data-enabled solutions, as well as making the company more agile to respond to the unique needs of its markets and clients .”

BofA Securities acted as financial advisor to Bayer while Hengeler Mueller acted as legal advisor.

About Bayer

Bayer is a global company with core competencies in the life science areas of health and nutrition. Its products and services are designed to help people and the planet thrive by supporting efforts to meet the grand challenges of a growing and aging world population. Bayer is committed to driving sustainable development and making a positive impact with its businesses. At the same time, the Group wants to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality worldwide. In the 2021 financial year, the group employed around 100,000 people and generated sales of EUR 44.1 billion. R&D expenses before special items amounted to 5.3 billion euros. For more information, visit

About Cinven

Cinven is a leading international private equity firm focused on building world-class global companies. Its funds invest in six key sectors: business services, consumer, financial services, healthcare, industrials and TMT (technology, media and telecoms). Cinven has offices in London, New York, Frankfurt, Paris, Milan, Madrid, Guernsey and Luxembourg. Cinven acts responsibly towards its portfolio companies, their employees, suppliers, local communities, the environment and society.

tia (2022-0037E)

Forward-Looking Statements

This release may contain certain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports, which are available on Bayer’s website at The Company undertakes no obligation to update or conform to these forward-looking statements them to future events or developments.

Leave a Comment